Pharmaceutical News

RSS
Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

MedImmune and Medarex have announced a collaboration to develop antibodies

MedImmune and Medarex have announced a collaboration to develop antibodies

FDA approval of Tysabri, for the treatment of multiple sclerosis

FDA approval of Tysabri, for the treatment of multiple sclerosis

Topical cream alternative to Vioxx

Topical cream alternative to Vioxx

FDA incapable of protecting America against another Vioxx

FDA incapable of protecting America against another Vioxx

FDA approves Vesicare (solifenacin succinate) for the treatment of overactive bladder

FDA approves Vesicare (solifenacin succinate) for the treatment of overactive bladder

Information about serious adverse effects of cerivastatin were known within months after drug launched

Information about serious adverse effects of cerivastatin were known within months after drug launched

Hetero Drugs withdraws antiretrovirals

Hetero Drugs withdraws antiretrovirals

AstraZeneca reconfirms the safety of Crestor

AstraZeneca reconfirms the safety of Crestor

FDA approves Tarceva (erlotinib)

FDA approves Tarceva (erlotinib)

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

Vaccinex and Biocon to co-develop at least four therapeutic antibody products

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

FDA clarifies it's position on Vioxx

FDA clarifies it's position on Vioxx

Canadian prescription drugs

Canadian prescription drugs

Eisai In-licenses Anti-hepatitis B Agent clevudine From Bukwang Pharm

Eisai In-licenses Anti-hepatitis B Agent clevudine From Bukwang Pharm

FDA commits to use of radio frequency identification (RFID) technology

FDA commits to use of radio frequency identification (RFID) technology

Sildenafil tablets will soon have small radio frequency tags

Sildenafil tablets will soon have small radio frequency tags

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.